Anavex Life Sciences Corp. (AVXL)

Anavex Life Sciences Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Cash & Equivalents	118.33	102.58	132.19	151.02	149.16	152.11
Cash & Short-Term Investments	118.33	102.58	132.19	151.02	149.16	152.11
Cash Growth	16.96%	-22.40%	-12.47%	1.25%	-1.94%	420.04%
Other Receivables	1	0.81	2.45	2.71	3.19	9.14
Receivables	1	0.81	2.45	2.71	3.19	9.14
Prepaid Expenses	0.82	0.43	0.93	0.65	0.35	0.37
Total Current Assets	120.14	103.82	135.57	154.39	152.71	161.62
Total Assets	120.14	103.82	135.57	154.39	152.71	161.62

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Accounts Payable	3.66	4.25	9.63	4.32	3.83	4.74
Accrued Expenses	4.04	3.37	4.28	5.99	5.95	5.61
Current Unearned Revenue	-	1.33	1.4	2.22	0.44	0.44
Total Current Liabilities	7.69	8.95	15.3	12.53	10.21	10.8
Total Liabilities	7.69	8.95	15.3	12.53	10.21	10.8

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Common Stock	0.09	0.09	0.09	0.08	0.08	0.08
Additional Paid-In Capital	498	477.23	456.25	434.84	387.98	348.33
Retained Earnings	-385.64	-382.45	-336.07	-293.07	-245.56	-197.59
Shareholders' Equity	112.45	94.87	120.26	141.85	142.49	150.82
Total Liabilities & Equity	120.14	103.82	135.57	154.39	152.71	161.62

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Net Cash (Debt)	118.33	102.58	132.19	151.02	149.16	152.11
Net Cash Growth	16.96%	-22.40%	-12.47%	1.25%	-1.94%	420.04%
Net Cash Per Share	1.31	1.20	1.58	1.89	1.94	2.18
Filing Date Shares Outstanding	92.7	89.35	84.82	82.09	77.96	76.02
Total Common Shares Outstanding	92.7	86.67	84.8	82.07	77.94	75.92
Working Capital	112.45	94.87	120.26	141.85	142.49	150.82
Book Value Per Share	1.21	1.09	1.42	1.73	1.83	1.99
Tangible Book Value	112.45	94.87	120.26	141.85	142.49	150.82
Tangible Book Value Per Share	1.21	1.09	1.42	1.73	1.83	1.99

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 25, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 31, 2026

Data Sources Report a data error